OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
I am an Associate Professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School. My lab is focused on statistical genetics approaches to understand the mechanisms of cancer risk, germline-somatic interactions, and response to treatment. We have led the development the Transcriptome-Wide Association (TWAS) and Regulome/Cistrome-Wide Association methodologies to identify cancer risk mechanisms using molecular and epigenetic data. We have also developed multiple methods to infer genetic data from large-scale tumor sequencing and incorporate Real World clinical outcomes for biomarker analyses, including the study of host influences on immunotherapy outcomes. Earlier in my training, I also worked on algorithms to identify genetic relatedness in large data, such as the GERMLINE method for efficient Identity By Descent detection.
